amifostine anhydrous and calcitriol

amifostine anhydrous has been researched along with calcitriol in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fallon, M; Goldfarb, S; Walker, ST; Weiss, J	1
Bonjour, JP; Caverzasio, J; Hirschel-Scholz, S	1
Beitler, JJ; Bruckner, H; Goldberg, G; Haynes, H; Hochster, H; Holland, JF; Mandeli, J; Runowicz, C; Smith, H; Wadler, S	1

Reviews

1 review(s) available for amifostine anhydrous and calcitriol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for amifostine anhydrous and calcitriol

Article	Year
Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:8 Topics: Adult; Aged; Amifostine; Calcitriol; Calcium; Calcium, Dietary; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Hypocalcemia; Middle Aged; Parathyroid Hormone; Radiation Injuries; Uterine Cervical Neoplasms	1993

Article

Year

Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:8

Topics: Adult; Aged; Amifostine; Calcitriol; Calcium; Calcium, Dietary; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Hypocalcemia; Middle Aged; Parathyroid Hormone; Radiation Injuries; Uterine Cervical Neoplasms

1993

Other Studies

3 other study(ies) available for amifostine anhydrous and calcitriol

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat. The Journal of pharmacology and experimental therapeutics, 1986, Volume: 238, Issue:3 Topics: Amifostine; Animals; Bone Resorption; Calcitriol; Carcinoma 256, Walker; Female; Glutathione; Hypercalcemia; In Vitro Techniques; Male; Organothiophosphorus Compounds; Osteosarcoma; Parathyroid Hormone; Rats; Rats, Inbred Strains	1986
Prevention of parathyroid hormone-dependent nephrocalcinosis by chronic administration of the organic phosphorothioate WR-2721. Calcified tissue international, 1987, Volume: 40, Issue:2 Topics: Amifostine; Animals; Calcinosis; Calcitriol; Calcium; Cyclic AMP; Glomerular Filtration Rate; Hyperparathyroidism; Kidney; Kidney Diseases; Male; Organothiophosphorus Compounds; Parathyroid Hormone; Rats; Rats, Inbred Strains	1987